% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@PHDTHESIS{Mhl:1024868,
author = {Möhl, Ninon},
othercontributors = {De Laporte, Laura and Pich, Andrij},
title = {{S}ynthetic anisotropic multiphasic hydrogels for in vitro
tissue models},
school = {RWTH Aachen University},
type = {Dissertation},
address = {Aachen},
publisher = {RWTH Aachen University},
reportid = {RWTH-2026-00387},
pages = {1 Online-Ressource : Illustrationen},
year = {2025},
note = {Veröffentlicht auf dem Publikationsserver der RWTH Aachen
University 2026; Dissertation, RWTH Aachen University, 2025},
abstract = {The regeneration of complex, hierarchically organized
native tissue and organs requires approaches that can
provide directional guidance for cells. While most
injectable hydrogels enable minimally invasive delivery and
adaptable properties such as stiffness and degradation cues,
they remain mostly isotropic and do not present cellular
guidance cues. To overcome this limitation, multiphasic
anisotropic hydrogels have been developed, employing
external triggers (electrical, light, sound, or magnetic
stimuli) or mechanical deposition. One emerging approach
involves the use of rod-shaped microgels as tissue
engineering building blocks. They offer injectability,
porosity, and biochemical functionality to guide cells in
three-dimensional (3D) tissue engineering constructs. A
fully synthetic 3D kidney disease model designed to overcome
current limitations in in vitro systems was developed.
Current kidney organoid or microfluidic platforms lack
mature tissue development, scalability, and control over
spatial organization. Our platform is composed of a
compartmentalized poly(ethylene glycol) (PEG)-based hydrogel
matrix comprising anisometric PEG microgels that enable
structural organization of a triple co-culture of key renal
cell types, including epithelial cells (CD10$^+$),
endothelial cells (CD31$^+$), and pericytes
(PDGFR$\beta^+$). The functionality of our model was
validated by inducing fibrosis through TGF$\beta$,
highlighting the potential of this system as a scalable and
tunable disease model. Furthermore, a robust and scalable
method has been established to produce degradable rod
microgels in a microfluidic high-throughput manner. Here, a
combinative approach of step-emulsification followed by
consecutive droplet distribution and confinement on a single
microfluidic device was developed. The potential and
feasibility of the microfluidic design are highlighted by
using two photo-initiated PEG-based polymerization
chemistries and comparing them side by side. Furthermore, we
report advances using compartmentalized jet polymerization,
a microfluidic technique that now enables the continuous
production of rod microgels with adjustable stiffness,
aspect ratios, and sizes as small as 3 µm. These ultra-thin
rod microgels can be rendered magnetic using a novel
post-functionalization protocol developed in this thesis.
Additionally, this method is used to produce ultra-soft and
porous variants with pore sizes in the range of 2–5 µm.
Both microgel types were employed in cell experiments,
showing promising results when integrated as
magneto-responsive microgels inside an Anisogel or as 3D
cell-assembled tissue constructs. Finally, this thesis
introduces an alternative cross-linking approach to the
elastic hydrogel matrix used for the Anisogel system. A
PEG-based hydrogel cross-linked through dynamic covalent
bonds is synthesized and analyzed. Different polymer
architectures were compared and their influence on the
hydrogel properties assessed. Furthermore, different
biocompatible catalysts are introduced to enhance the
reaction kinetics at physiological pH making this hydrogel
matrix promising for future cell experiments.},
cin = {154610 / 150000},
ddc = {540},
cid = {$I:(DE-82)154610_20140620$ / $I:(DE-82)150000_20140620$},
pnm = {DFG project G:(GEPRIS)445703531 - KFO 5011: Integration
neuer Methoden zur Verbesserung von translationaler
Nierenforschung (445703531)},
pid = {G:(GEPRIS)445703531},
typ = {PUB:(DE-HGF)11},
doi = {10.18154/RWTH-2026-00387},
url = {https://publications.rwth-aachen.de/record/1024868},
}